Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an ... Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups. Mehr anzeigen
Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment Study PR Newswire NEW YORK, Oct. 29...
Hoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer's Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now Underway PR Newswire NEW YORK, Oct. 15, 2024 NEW...
Hoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZ PR Newswire NEW YORK, Sept. 17, 2024 Early observations suggest that the vehicle-treated Alzheimer's mice exhi...
Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a Trial PR Newswire NEW YORK, Sept. 5, 2024 Dana-Farber Cancer Institute in Boston, MA and Montefiore Medical Center in...
Hoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001 PR Newswire NEW YORK, Sept. 5, 2024 Cancer Patient Ceased...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.26 | 29.8850574713 | 0.87 | 1.23 | 0.7601 | 104402 | 0.84541575 | CS |
| 4 | 0.25 | 28.4090909091 | 0.88 | 1.33 | 0.7601 | 980766 | 0.96123032 | CS |
| 12 | 0.375 | 49.6688741722 | 0.755 | 1.5 | 0.6506 | 3641768 | 1.18383341 | CS |
| 26 | -0.09 | -7.37704918033 | 1.22 | 1.5 | 0.58 | 2065144 | 1.14732993 | CS |
| 52 | 0.06 | 5.60747663551 | 1.07 | 1.73 | 0.58 | 1218047 | 1.18346054 | CS |
| 156 | -19.62 | -94.5542168675 | 20.75 | 43.75 | 0.58 | 1558174 | 15.25855752 | CS |
| 260 | -111.37 | -98.9955555556 | 112.5 | 196 | 0.58 | 1431211 | 29.8203674 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
